Abstract
Background Social symptomatology quantified by clinical interview (Autism Diagnostic Observation Schedule, ADOS) and self-report (Social Responsiveness Scale, SRS) indicate symptom severity in autism spectrum disorder (ASD). Reluctance to engage in interpersonal eye contact is a frequently observed behavioral hallmark, though neural bases for these difficulties and relation to symptomatology are not understood. We test the hypothesis that eye contact in ASD activates atypical neural mechanisms that are related to individual differences in symptomatology.
Methods Neural activity represented by hemodynamic signals was acquired by functional near-infrared spectroscopy (fNIRS) during real person-to-person eye contact (confirmed by eye-tracking) for 17 adult ASD (3 female, 14 male) and 19 typically-developed (TD) participants (8 female, 11 male). Assessment of social function was based on ADOS scores for ASD participants and SRS scores for the combined group of ASD and TD participants.
Results Individual ADOS scores were negatively correlated (r = -0.69) with individual fNIRS beta-values (representing strength of hemodynamic signals) within clusters in the right dorsal stream regions: somatosensory cortices, angular gyrus, and supramarginal gyrus. Hemodynamic responses in the right dorsolateral prefrontal cortex (DLPFC) were also negatively correlated (r = -0.77) with ADOS scores. Similarly, SRS scores for the combined ASD and TD groups were also negatively correlated (r = -0.58) with somatosensory cortices and the supramarginal gyrus.
Conclusions These findings are consistent with the hypothesis that neural mechanisms in the dorsal stream and DLPFC are related to social symptomatology and implicate high-level interactive face and eye-processing systems as potential neurobiological markers of ASD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was partially supported by the National Institute of Mental Health of the National Institutes of Health under award numbers 1R01MH111629 (PIs JH and JCM); R01MH107513 (PI JH); 1R01MH119430 (PI JH); U19MH108206 (PI JCM); R01 MH107426 (PI JCM); R01 MH100173 (PI JCM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Research Protection Program of Yale University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets analyzed for this study will be made available upon request at fmri.org/ ENDAR and the NIH Data Archive.
